Delivers Positive Free Cash Flow 1 of $6.5 Million Increases Total Quarterly Net Revenue 1 by 12% YoY to $83.4 Million , Record Net Revenue 1 of $47.
2 Million in Global Medical Cannabis Generates Adjusted EBITDA 1 of $4.9 Million , a YoY increase of 87% Ends the Fiscal Quarter with a Debt-Free Cannabis Business 2 and a Cash Position of ~$182 Million EDMONTON, AB , Aug. 7, 2024 /PRNewswire/ - Aurora Cannabis Inc.
(the "Company" or "Aurora" ) (NASDAQ: ACB ) (TSX: ACB), a leading Canada -based global medical cannabis company, today announced its financial and operational results for the first quarter fiscal 2025. "This was a milestone quarter for Aurora, as we delivered strong net revenue 1 growth, a substantial increase in adjusted EBITDA 1 , and positive free cash flow 1 . Our impressive performance was driven by record net revenue 1 in the rapidly growing global medical cannabis segment, and we look forward to building on our achievements in key markets such as Germany , Australia , and the UK throughout fiscal 2025 and beyond.
The quarter was further supported by a record contribution from our Bevo plant propagation business, underscoring the strength of our diversified business model," said Chief Executive Officer Miguel Martin . "The progress we made during the quarter sets a strong foundation for the rest of the fiscal year, and with our continued commitment to operational excellence and strategic growth, we are well-positioned to sustain this positive momentum. Our growt.